Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Avoid common budget mistakes by knowing what not to include in a budget. This quick intro highlights pitfalls and simple tweaks to improve your spending plan.
26,809 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
When a stock slips, smart investors look past the temporary dip. Domino's remains a dominant player with growing digi...
A little-known robotics ETF is trading at a discount, offering broad exposure as robotics ETFs will dominate in the c...
Teladoc has faced a challenging stretch after its pandemic boom. This guide examines whether teladoc stock going read...
AI investing can feel crowded, but a pair of no-brainer artificial intelligence (ai) stocks stand out for durable gro...
A premium fitness brand attracts a substantial fund investment while its stock lags. This piece breaks down what it m...
The Mortgage Bankers Association and allied groups urge the VA to simplify loss-mitigation rules for VA-backed loans,...
Affirm stock has caught investors' attention as it swings between growth bets and risk concerns. This guide breaks do...
Prospect Capital offers a striking 20%+ yield, but its long-run performance raises questions. This article lays out a...
When weighing broad tech exposure against a semiconductor tilt, Fidelity's ETF offers lower fees and wider reach. Lea...
The battle over who controls listing access is intensifying as AI powered search and private inventories reshape the ...
Digital mortgage tools are reshaping how buyers shop for homes as rates swing and inventories stay tight. The latest ...